Antiproliferative and antiangiogenic effects of partially purified Luffa acutangula fruit extracts on human lung adenocarcinoma epithelial cell line (A-549)

Order of Publishing in Issue: 
Volume :3
Issue :4
October, 2009 - December, 2009
Page No: 
Boreddy Purushotham Reddy, R. Kannaiah Goud, S. Venkata Mohan*, P. N. Sarma
Bioengineering and Environmental Centre, Indian Institute of Chemical Technology Hyderabad 500 607, India

Abstract : The present study was undertaken to evaluate the possibility of Luffa acutangula (cucurbitaceae family) fruit as a potential anticancer agent by examining antiproliferative and antiangiogenic activities. Fruit methanolic extract  showed significant antiproliferative activity (IC-50, 131.63±2.31 ug/ml) on human lung adenocarcinoma epithelial cell line (A-549). The extractwas partially purified by chromatography. Fraction F2-3 showed most potent antiproliferative activity (IC-50, 7.61±1.03 ug/ml)  and was further evaluated for antiangiogenic activity by evaluating vascular endothelial growth factor (VEGF), matrix metalloproteinases-2 (MMP-2) and matrix metalloproteinases-2 (MMP-9) as in-vitro, chick chorioallantoic membrane (CAM) as an in-vivo model for VEGF. VEGF and both MMP protein expressions were significantly inhibited in F2-3 treated A-549 cells compared to control cells (VEGF: 4.36±0.47 and 14±0.75 pg/ml, MMP-2: 10.17±1.3 and 20.28±1.68, MMP-9: 12.93±1.70 and 21.12±2.12 ng/ml, respectively). Egg chorioallantoic membrane treated with F2-3 fraction (10 ?g) showed clear avascular zones compared to phosphate buffered saline (PBS) treated eggs. In conclusion, ourdata provides a scientific proof for Luffa acutangula as a potential antitumor agent.

Vascular endothelial growth factor (VEGF), Matrix metalloproteinases MMP), Extracellular matrix (ECM), Chick chorioallantoic membrane (CAM) model.
Paper-7.PDF192.35 KB

To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.



Upcoming 0 events

  • No upcoming events available

User login